Nurse Practitioner, Family · Baton Rouge, LA
NPI
1336630847
Since 2018
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
9118 Bluebonnet Centre Blvd Fl 2
Baton Rouge, LA, 70809
Phone (225) 368-2311
Groups this clinician bills Medicare through
Medicare paid, 2024
$16K
268 services
Medicare patients, 2024
31
Average age 38
Drug cost, 2024
$1.7M
358 prescriptions
Company payments, 2025
$1,470
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tabitha Jones was code 99214 (office e&m - established), 189 times for 29 patients. In total Tabitha Jones billed 268 services in 4 codes, and Medicare paid $16K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-10-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 189 | 29 | $55.66 | $11K |
| 99214 Office E&M - Established | Office | 76 | 18 | $75.79 | $5,760 |
By year: 2022 $20K for 344 services; 2023 $17K for 296 services; 2024 $16K for 268 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tabitha Jones prescribed most often to Medicare patients was Hydroxyurea, with 91 prescriptions and refills. In total Tabitha Jones wrote 358 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxyurea Generic | 91 | 122 | 24 | $2,839 |
| Promethazine Hcl Generic | 78 | 78 | 15 | $364 |
| Ferriprox (2 Times A Day) Deferiprone | 41 | 41 | Under 11 | $1.2M |
| Oxbryta Voxelotor | 35 | 35 | Under 11 | $424K |
| Eliquis Apixaban | 18 | 18 | Under 11 | $11K |
| Ondansetron Odt Ondansetron | 15 | 15 | Under 11 | $144 |
| Potassium Chloride Generic | 13 | 19 | Under 11 | $850 |
Brand drugs: 112 claims; generic drugs: 246 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tabitha Jones $1,470 ($1,470 in general payments such as food, travel and fees) from 26 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $249.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 13 | $249 |
| Daiichi Sankyo Inc. 4568.T | 8 | $174 |
| GlaxoSmithKline, LLC. GSK | 9 | $164 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $143 |
| Janssen Biotech, Inc. JNJ | 9 | $142 |
| Merck Sharp & Dohme LLC MRK | 4 | $74.52 |
| Pfizer Inc. PFE | 3 | $57.37 |
| Eisai Inc. 4523.T | 2 | $43.81 |
| Alexion Pharmaceuticals, Inc. AZN | 2 | $42.99 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $40.92 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.